Evidence map›Paper›PMID 34439493›Full record

ArticleAntioxidants (Basel, Switzerland)2021

Engineered Sumoylation-Deficient Prdx6 Mutant Protein-Loaded Nanoparticles Provide Increased Cellular Defense and Prevent Lens Opacity.

Bhavana Chhunchha, Eri Kubo, Uday B Kompella, Dhirendra P Singh

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Loss of Peroxiredoxin 6 Drives Age-Related Klf9/NF-Antioxidants (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Lipid Nanostructures for Antioxidant Delivery.Antioxidants (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Bhavana ChhunchhaOphthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0000-0001-9613-8765
Eri KuboDepartment of Ophthalmology, Kanazawa Medical University, Kanazawa 9200265, Ishikawa, Japan.ORCID 0000-0001-6789-9311
Uday B KompellaDepartments of Pharmaceutical Sciences, Ophthalmology, and Bioengineering, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Dhirendra P SinghOphthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha, NE 68198, USA.
University of Nebraska Medical Center · USKanazawa Medical University · JPUniversity of Colorado Anschutz Medical Campus · US

Funding

Regulation and Function of Prdx6 in eye lens during Aging & Oxidative StressR01EY024589 · NEI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI SINGH, DHIRENDRA P · 2014 to 2018
$1.9M
NEI NIH HHS R01 EY024589NIH HHS EY024589
6 · The paper itself

Abstract

Aberrant Sumoylation-mediated protein dysfunction is involved in a variety of oxidative and aging pathologies. We previously reported that Sumoylation-deficient Prdx6K

Indexed as

antioxidantsnano-formulationnanoparticlesoxidative stressperoxiredoxin 6protective mutationsumoylationtransduction domain

Identifiers

PMID34439493
PMCPMC8389307
OpenAlexW3189466861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.